A genome-scale screen for synthetic drivers of T cell proliferation-Reference-Cited by-同舟云学术

A genome-scale screen for synthetic drivers of T cell proliferation

Published:2022-03-16 Issue:7902 Volume:603 Page:728-735
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Legut Mateusz^ORCID,Gajic Zoran^ORCID,Guarino Maria,Daniloski Zharko^ORCID,Rahman Jahan A.^ORCID,Xue Xinhe,Lu Congyi,Lu Lu^ORCID,Mimitou Eleni P.^ORCID,Hao Stephanie^ORCID,Davoli Teresa,Diefenbach Catherine,Smibert Peter^ORCID,Sanjana Neville E.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

https://www.nature.com/articles/s41586-022-04494-7.pdf

Reference76 articles.

1. Abramson, J. S. et al. Transcend NHL 001: immunotherapy with the CD19-directed CAR T-cell product JCAR017 results in high complete response rates in relapsed or refractory B-cell non-Hodgkin lymphoma. Blood 128, 4192–4192 (2016).

2. Shifrut, E. et al. Genome-wide CRISPR screens in primary human T cells reveal key regulators of immune function. Cell 175, 1958–1971 (2018).

3. Dong, M. B. et al. Systematic immunotherapy target discovery using genome-scale in vivo CRISPR screens in CD8 T cells. Cell 178, 1189–1204 (2019).

4. Chen, Z. et al. In vivo CD8+ T cell CRISPR screening reveals control by Fli1 in infection and cancer. Cell 184, 1262–1280 (2021).

5. Kabelitz, D., Serrano, R., Kouakanou, L., Peters, C. & Kalyan, S. Cancer immunotherapy with γδ T cells: many paths ahead of us. Cell. Mol. Immunol. 17, 925–939 (2020).

Cited by 112 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors;Cellular & Molecular Immunology;2024-08-12

2. Industry updates from the field of stem cell research and regenerative medicine in May 2024;Regenerative Medicine;2024-08-05

3. Boosting CAR-T cell therapy with CRISPR technology;hLife;2024-08

4. Epigenome editing technologies for discovery and medicine;Nature Biotechnology;2024-07-29

5. CRISPR-based genetic screens advance cancer immunology;Science China Life Sciences;2024-07-23